The role of oxidants and antioxidants in inflammatory bowel disease (IBD) have been actively explored since the early 198Os, starting with the role of the respiratory burst of neutrophils and ischemia in bowel pathology. Since that time the enzymatic components contributing to the pool of reactive oxygen species including , superoxide, H2O2 and lipid hydroperoxides and the counteracting antioxidants, catalase, glutathione peroxidases (GPX), peroxiredoxins (PRDX), superoxide dismutases and others have been fleshed out. My perspective on IBD is from the role of the balance or imbalance of enzymatic oxidant sources and enzymatic antioxidants in the inflammatory process. I will present evidence on the involvement of oxidant and antioxidant processes in IBD, based as much as possible, on my experiences with GPXs. This will be about both the immune system and local bowel oxidant and antioxidant systems. As GPXs are generally selenium-dependent, possible deficiencies in selenium uptake in active IBD and the impact on GPX expression is explored. The more recently introduced ferroptosis, an iron-dependent lipid peroxidation based pathological process, will be reviewed for its possible involvement in IBD.